BioWorld Asia

June 6, 2007

Bavarian's Smallpox Vaccine Pact Worth Up To $1.6 Billion

Bavarian Nordic A/S could earn a total of $1.6 billion from its contract with the U.S. Department of Health and Human Services to supply a stockpile of next-generation safe smallpox vaccines. (BioWorld International) Read More

UK Ponders Plan Promoting Payment Upon Performance

Lost Copies Of Genes Dictate Risk Of Autoimmune Diseases

Soaring Interest In RNA Field Nets Exiqon $62.7 Million IPO

Evolutec Calling It Quits After Product Failure

Other News To Note

Pharmaxon Obtains Mimetic Peptide For Cell Mobility Drugs

Transgene In Line For €10M Milestone On CIN Compound

No Abstract Read More

Industry Rejoices at Fudged EU Advanced Therapies Agreement

ASCO Roundup

Today's news in brief

BioWorld

BioWorld briefs for Dec. 27, 2024.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for December 24, 2024.

Illustration of neurons with Lewy bodies

Enhanced Cognition: Lewy body dementia phase II pumps stock

BioWorld

Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...

Experimental mRNA gene therapy suppresses preeclampsia in mice

BioWorld MedTech

A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...

Lab glassware and antibodies art concept

Probing bidirectional cancer-autoimmune link can yield new targets

BioWorld Science

Cancer and autoimmunity are “often thought of as being at opposite ends of the immune response,” Ana Anderson told her audience at a joint meeting of the NIH’s...